Publication date: Feb 11, 2020
Malaria is major public health concerns which continues to claim the lives of more than 435,000 people each year. The challenges with anti-malarial drug resistance and detection of low parasitaemia forms an immediate barrier to achieve the fast-approaching United Nations Sustainable Development Goals of ending malaria epidemics by 2030. In this Opinion article, focusing on the recent published technologies, in particularly the nuclear magnetic resonance (NMR)-based diagnostic technologies, the authors offer their perspectives and highlight ways to bring these point-of-care technologies towards personalized medicine. To this end, they advocate an open sourcing initiative to rapidly close the gap between technological innovations and field implementation.
Open Access PDF
Veiga, M.I. and Peng, W.K. Rapid phenotyping towards personalized malaria medicine. 06320. 2020 Malar J (19):1.
|disease||MESH||Plasmodium falciparum malaria|
- Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma.
- Precision and Personalized Medicine and anti-TB treatment: Is TDM feasible for programmatic use?